Pharma

Your Article Summary

See Latest Articles

Bayer Schering Pharma Announces New Data on Novel Anti-cancer Compound BAY 73-4506
BayNews International, 06/11/09

Bayer Schering Pharma AG announced results from Phase I and II trials of BAY 73-4506, a potent oral multi-kinase inhibitor currently being studied in multiple tumor types. These data were presented at the 45th Annual Meeting of the American Society of Clinical Oncology.

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
BayNews International, 12/03/09

GSK Update: GSKs Arepanrix H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09

Bayer Schering Pharma to collaborate with Micromet on novel approach to cancer therapy
BayNews International, 12/02/09

 See all of Research & Development